Press Releases for the Psychedelics Industry

Psychedelics News

Press Releases

25 May 2021

Tryp Therapeutics Partners with Alcami for Proprietary Formulations

By Microdose

Press Releases

19 May 2021

Lobe Sciences Secures Production and Supply Agreement for Vitamind Consumer Packaged Goods Products

By Microdose

Press Releases

18 May 2021

Entheon Biomedical Announces DMT Drug Supply Agreement with Ofichem Group

Vancouver, British Columbia–(Newsfile Corp....

By Microdose

Press Releases

14 May 2021

Entheon Biomedical Corp. Provides Corporate Update

Launch of Psychedelics DNA Test Kit Phase 1 clinical trial for DMT progressing as planned Pre-clinical In Vivo work scheduled to start at Israeli CRO Strengthened expertise focused on driving...

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

11 May 2021

Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application

Partnership Aimed at Delivering Psychedelic Capsule for Dosing Study in Human Clinical Trial VANCOUVER, BC, May 11, 2021 /CNW/ - Numinus Wellness Inc....

By Microdose

Press Releases

11 May 2021

Psyched Wellness Hires the National Research Council of Canada to Test AME-1

Toronto, Ontario–(Newsfile Corp....

By Microdose

Press Releases

10 May 2021

Numinus Congratulates MAPS on Phase 3 Clinical Trial Demonstrating Significant Benefits of MDMA-Assisted Therapy for Severe PTSD

Numinus and Multidisciplinary Association for Psychedelic Studies collaboration will conduct follow-on Compassionate Access trial in real-world setting in Vancouver, Canada VANCOUVER, May 10, 2021 /CNW/ – Numinus Wellness Inc....

By Microdose

Press Releases

10 May 2021

NeonMind to Present at the Benzinga Global Small Cap Conference

Vancouver, British Columbia–(Newsfile Corp....

By Microdose

Press Releases

10 May 2021

Tryp Therapeutics Partners with Clinlogix for Clinical Trial Support

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result